December 19, 2019 / 10:20 PM / a month ago

BRIEF-G3 Pharmaceuticals - Signs Global Development And Option Agreement With Nestlé Health Science

Dec 19 (Reuters) - Nestle SA:

* G3 PHARMACEUTICALS - ANNOUNCED SIGNING OF EXCLUSIVE GLOBAL DEVELOPMENT AND OPTION AGREEMENT WITH NESTLÉ HEALTH SCIENCE

* G3 PHARMACEUTICALS - AGREEMENT FOR DEVELOPMENT OF PLANT-DERIVED GALECTIN-3 INHIBITORS FOR USE IN NUTRITIONAL SOLUTIONS

* G3 PHARMACEUTICALS - UNDER AGREEMENT NESTLÉ HEALTH SCIENCE TO PROVIDE FUNDING FOR RESEARCH AND DEVELOPMENT ACTIVITIES

* G3 PHARMACEUTICALS - UNDER AGREEMENT G3 PHARMACEUTICALS WILL BE ELIGIBLE FOR CERTAIN MILESTONE PAYMENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below